Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings ...

Night - Mostly clear. Winds NW at 5 to 11 mph (8 to 17.7 kph). The overnight low will be 31 °F (-0.6 °C). Sunny with a high of 38 °F (3.3 °C). Winds variable at 7 to 14 mph (11.3 to 22.5 kph ...

Pantheon Resources PLC will drill additional wells in Kodiak based on improved contingent resource estimates based on acreage expansion and improved updip reservoir conditions. Pantheon Resources ...

However, Kodiak believes achieving and sustaining a healthier and more balanced lifestyle doesn’t have to be a heavy lift. Nestled among the Wasatch Mountains of Park City, Utah, Kodiak was ...

Looking for information on Kodiak Airport, Kodiak, United States? Know about Kodiak Airport in detail. Find out the location of Kodiak Airport on United States map and also find out airports near to ...

Kodiak Gas Services press release (NYSE:KGS): Q4 EPS of -$0.09 may not be comparable to consensus of $0.28. Revenue of $225.98M (+25.7% Y/Y) beats by $3.46M. Adjusted EBITDA(1) for the quarter ...

John Borgeson; Senior Vice President and Chief Financial Officer; Kodiak Sciences Inc Victor Perlroth; Chairman and Chief Executive Officer; Kodiak Sciences Inc Pablo Velazquez-Martin; Senior Vice ...

Shares of Kodiak Sciences Inc. KOD fell sharply during Thursday’s session after the company reported a wider-than-expected fourth-quarter loss. Kodiak Sciences posted a quarterly loss of $1.13 ...

Kodiak Sciences (NASDAQ:KOD) just reported results for the fourth quarter of 2023. Kodiak Sciences reported earnings per share of -$1.13. This was below the analyst estimate for EPS of -77 cents ...

Kodiak Sciences Inc. KOD incurred a loss per share of $1.13 in the fourth quarter of 2023, wider than the Zacks Consensus Estimate of a loss of 86 cents. The company had incurred a loss of $1.35 ...

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate ...